Normal Contact Lens Wearers

0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Abbott
AbbottABBOTT PARK, IL
1 program
Multi-purpose disinfecting solutionN/A2 trials
Active Trials
NCT01847105Unknown54Est. May 2014
NCT01294917Completed40Est. Aug 2011

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AbbottMulti-purpose disinfecting solution
AbbottMulti-purpose disinfecting solution

Clinical Trials (2)

Total enrollment: 94 patients across 2 trials

NCT01847105AbbottMulti-purpose disinfecting solution

Assessing Patient Comfort With Two Different Multi-Purpose Disinfecting Solutions

Start: Jun 2013Est. completion: May 201454 patients
N/AUnknown
NCT01294917AbbottMulti-purpose disinfecting solution

Comparison of a New Abbott Medical Optics (AMO) Multi-Purpose Solution (MPS) to Existing Contact Lens Regimens

Start: Feb 2011Est. completion: Aug 201140 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space